Signaling
Science NewsView All Science News
11/10/2018 | The 2018 guideline addresses the practical management of patients with high blood cholesterol and related disorders.
11/10/2018 | This AHA/ACC special report serves as a companion to the 2018 Cholesterol Clinical Practice Guidelines and 2017 Hypertension Clinical Pra...
11/10/2018 | Science News coverage of selected presentations and interviews from AHA's Scientific Sessions 2018. Nov. 10-12, 2018 in Chicago, Ill.
Vascular Discovery: From Genes to Medicine 2019
May 14–16, 2019
Boston, Massachusetts
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Basic Cardiovascular Sciences (BCVS)
The American Heart Association (AHA) created the Council on Basic Cardiovascular Sciences (BCVS) in 1999 to promote research and education. Our goal is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical cardiovascular disease. Special emphasis is placed on integrating molecular/cellular and physiological approaches to address problems relating to functional genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology and peripheral vascular disease.
Joseph C. Wu, MD, PhD, FAHA
Chair, Council on Basic Cardiovascular Sciences
Council on Genomic and Precision Medicine (GPM)
The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.
Thomas J. Wang, MD, FAHA
Chair, Council on Genomic and Precision Medicine
Council on Peripheral Vascular Disease (PVD)
The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Aruna D. Pradhan, MD, MPH
Chair, Council on Peripheral Vascular Disease
Since 1949, the American Heart Association has spent more than $4 billion on scientific research (opens in a new window) to increase our knowledge about cardiovascular diseases and stroke. Our research programs have contributed to many important scientific advances, which touch every community.